Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 196
Appendix
I
BIOGRAPHICAL NOTES ON COMMITTEE MEMBERS
AND CONSULTANTS
JAY P. SANFORD is president of the Uniformed Services University of
the Health Sciences (USUHS) and dean of the F. Edward Hebert School of
Medicine, USUHS, Bethesda, Maryland. Prior to his arrival at USUHS in
1975, he was professor of internal medicine and chief of the
Infectious Disease Service at the University of Texas Southwestern
Medical School, Dallas. Dr. Sanford is a member of the Institute of
Medicine and has served on numerous scientific advisory boards and on
the editorial boards of more than 10 scientific journals; he is a
former associate editor of the Journal _ Clinical Investigation. He
received his M.D. degree from the University of Michigan Medical
School.
MARSHALL H. BECKER is professor and chairman in the Department of
Health Behavior, School of Public Health, and professor in the
Department of Pediatrics, School of Medicine, at the University of
Michigan in Ann Arbor. From 1974 to 1977 he was associate professor
in the departments of pediatrics, behavioral sciences, and social
relations at Johns Hopkins University. He has published extensively
on such topics as beliefs and attitudes as determinants of
individuals' health-related behaviors, patient compliance with
prescribed regimens, diffusion of innovations among health
professionals, drug-prescr~bing patterns, and different approaches to
organizing the delivery of medical care. He is a medical sociologist
and holds M.P.H. and Ph.D. degrees from the University of Michigan.
LAWRENCE M. DeBROCK is assistant professor of economics at the
University of Illinois in Urbana-Champaign. His research has focused
on the effects of government policies on market outcomes, including
such areas as invention and innovation, energy, and health care. He
received his M.A. and Ph.D. degrees from Cornell University and his
B.A. from Bradley University.
ROGER B. DWORKIN is professor of law and Harry T. Ice Faculty
Fellow at the Indiana University School of Law, Bloomington, where he
has been on the faculty since 1968. He also has served as professor
of biomedical history at the University of Washington School of
196
OCR for page 197
197
Medicine. His primary research and public service activities involve
the relationship between law and the biomedical sciences. He was
educated at Princeton University and Stanford Law School.
BERNARD N. FIELDS is the Adele H. Lehman Professor and chairman of
the Department of Microbiology and Molecular Genetics at Harvard
Medical School, a position he has held since 1982. His research has
focused on the molecular basis of viral pathogenesis. He has served
on a number of scientific advisory boards, was chairman of the
Experimental Virology Study Section of the National Institutes of
Health, and is an editor of the Journal of Virology. He recently was
elected to membership in the National Academy of Sciences. He
received his M.D. degree from New York University Medical School and
his B.A. from Brandeis University. ~
JERK E. GOYAN is professor of pharmacy and pharmaceutical chemistry
and dean of the School of Pharmacy of the University of California,
San Francisco. From 1979 to 1981, he was commissioner of the U.S.
Food and Drug Administration. His research interests involve the
physical chemistry of dosage form design. He is a member of the
Institute of Medicine and has served on numerous scientific advisory
boards and committees related to his research interests, pharmacy
education, and drug regulation. He received his bachelor's degree in
pharmacy from the University of California, San Francisco, and his
Ph.D. degree in pharmaceutical chemistry from the University of
California, Berkeley.
HENRY G. GRABOWSKI has been at Duke University since 1972 and is a
professor of economics. He is also an adjunct scholar of the American
Institute of Public Policy Regulation. Professor Grabowski has held
visiting appointments at the Health Care Financing Administration and
the International Institute of Management in Berlin, Germany. He has
published numerous articles and books on the pharmaceutical industry,
including studies of the research and development process, the
international diffusion of new drugs, and the effects of various
government policy actions. He also has authored cost-benefit studies
of government regulatory actions in various other industrial sectors.
He has served as an advisor and consultant to several organizations,
including the National Academy of Engineering, the General Accounting
Office, and the Office of Technology Assessment. Professor Grabowski
received his undergraduate degree in engineering physics at Lehigh
University in 1962 and his Ph.D. in economics from Princeton
University in 1967.
SAMUEL L. KATZ is the Wilbur C. Davison Professor of Pediatrics and
chairman of the Department of Pediatrics at Duke University, a
position he has held since 1968. His research has focused on human
virology, infectious diseases, and immunization. He is a member of
the Institute of Medicine and has served on a variety of scientific
advisory boards, committees and consultative groups, and editorial
OCR for page 198
198
boards relating to problems in infectious diseases and immunization.
He received his M.D. degree from Harvard University and his B.A.
degree from Dartmouth College.
EDMUND W. KITCH is professor of law and member of the Center for
Advanced Studies, the University of Virginia. He is a member of the
bars of the U.S e Supreme Court, numerous federal courts, and the
states of Illinois and Kansas. He has written in the fields of
antitrust, industrial torts~and property, legal history,
constitutional law, and law and economics. He received his B.A.
degree from Yale University and his J.D. from the University of
Chicago. From 1965 to 1982 he was a member of the faculty of the
University of Chicago Law School. He has served the federal
government as special assistant to the Solicitor General (1972-1973)
and executive director of the Civil Aeronautics Board Committee on
Procedural Reform (1974-1975~.
LOUIS LASAGNA is academic dean of the medical school and dean of
the Sackler School of Graduate Biomedical Sciences at Tufts
University. Previously, he served as chairman of the Department of
Pharmacology and Toxicology at the University of Rochester Medical
School for 10 years. He is also director of the Center for the Study
of Drug Development, which moved from Rochester to Boston in 1984, and
has been chairman of the Advisory Board of the Center since its
inauguration in 1976. He led the first unit of clinical pharmacology
at Johns Hopkins University School of Medicine, where he held academic
appointments for 16 years prior to his move to Rochester. He is a
member of the Institute of Medicine. Dr. Lasagna received his B.S.
degree from Rutgers University and his M.D. from Columbia University.
MARTHA L. LEPOW has been professor of pediatrics and program
director of the Clinical Research Center at Albany Medical College
since 1979. She is a specialist in infectious diseases; her principal
research interest is in the development of vaccines against the
meningococcus and Hemophilus influenzas type b, the commonest cause of
meningitis in infants and young children. She has served on a number
of scientific committees and consultative groups. Dr. Lepow received
her B.A. degree from Oberlin College and her M.D. from Case Western
Reserve University.
DAVID W. MARTIN, JR. is vice-president of Research and Development
of Genentech, Inc. in South San Francisco, California. He is also
adjunct professor of medicine and biochemistry at the University of
California, San Francisco. He attended the Massachusetts Institute of
Technology and Duke University, from which he received the M.D. degree
in 1964. He is a member of the Recombinant DNA Advisory Committee of
the National Institutes of Health, serves on several editorial boards
of scientific journals, and is the major author and editor of HarPer's
Review of Biochemistry. His research involves inherited metabolic
diseases, particularly disorders of purine metabolism and
immunodeficiencies.
OCR for page 199
199
DONALD N. MEDEARIS, JR. is Charles Wilder Professor of Pediatrics,
Harvard Medical School, and chief, Children's Services, Massachusetts
General Hospital. He graduated from the University of Kansas in 1950
with an A.B. in chemistry and received his M.D. from Harvard in 1953.
He interned in internal medicine at Barnes Hospital, St. Louis, and
served a residency in pediatrics at Children's Hospital, Cincinnati.
He has served on the faculties of Johns Hopkins, Pittsburgh, and Case
Western Reserve, and on national advisory groups concerning general
research support, clinical research, immunization, and graduate
medical education. He is a member of the Institute of Medicine and
was a member of the President's Commission for the Study of Ethical
Problems in Medicine and Biomedical and Behavioral Research from 1979
to 1982.
THOMAS C. MERIGAN is the first holder of the George E. and Lucy
Becker Professorship in Medicine at Stanford University, and heads the
Division of Infectious Diseases at Stanford. He is both an active
clinician and an internationally known researcher in the field of
infectious disease. He has served on the editorial boards of 13
journals, edited 6 books, and published more than 330 scientific
papers. He has been a member of a number of national and
international scientific advisory committees, including those of the
National Institutes of Health, the Hartford and Lasker foundations,
the American Cancer Society, and the World Health Organization. He is
also a member of the Institute of Medicine. He received the
Guggenheim Fellowship Award in 1972 and the Borden Award for
Outstanding Research from the American Association of Medical Colleges
in 1973. He received his undergraduate degree with honors in 1955
from the University of California, Berkeley, and his M.D. in 1958 from
the University of California, San Francisco.
EDWARD A. MORTIMER, JR. has been Elisabeth Severance Prentiss
Professor and chairman of the Department of Epidemiology and Community
Health, and professor of pediatrics at the Case Western Reserve
University School of Medicine since 1975. From 1966 to 1975 he
chaired the Department of Pediatrics at the University of New Mexico.
His interests have been primarily in epidemiology, especially of
infectious diseases. He serves or has served on a number of advisory
groups concerned with immunization and control of infection. He
received his A.B. degree from Dartmouth College and his M.D. from
Northwestern University.
JANE E. SISK is a project director in the Health Program of the
congressional Office of Technology Assessment, a position she has held
since 1981. She recently completed a project on the medical devices
industry, and previously worked on studies of federal vaccine policies
and on cost-effectiveness analyses of influenza and pneumococcal
vaccines. From 1978 to 1981, she was a Veterans Administration
scholar based at the National Center for Health Services Research,
where she examined the use of medical technologies under different
financing and organizational arrangements. She received a Ph.D. in
OCR for page 200
200
economics from McGill University and a B.A. in international relations
from Brown University.
GENE STOLLERMAN is professor of medicine at Boston University
School of Medicine and chief of the General Internal Medicine Section
at University Hospital, Boston. From 1965 to 1981, he was professor
and chairman of the Department of Medicine at the University of
Tennessee College of Medicine, Memphis. He has served on many
scientific advisory boards and is the editor of Advances in Tnt~rn~ 1
Medicine and the "Capsule and Comments" section of Hospital Practice.
He received his A.B. degree from Dartmouth College and his M.D. from
the College of Physicians and Surgeons, Columbia University.
THOMAS H. WELLER is the Richard P. Strong Professor of Tropical
Public Health at Harvard, a position he has held since 1954. In that
year, he was awarded the Nobel Prize in Physiology and Medicine with
his colleagues John Enders and Frederick Robbins for work that led to
the polio vaccine. Trained as a pediatrician, his research has
focused on viral diseases of children and on tropical diseases. He is
a member of both the National Academy of Sciences and the Institute of
Medicine. He has served as senior advisor for research programs of
the World Health Organization, the U.S. Agency for International
Development, the National Institute of Allergy and Infectious Diseases
of the National Institutes of Health, and the Centers for Disease
Control. He received his A.B. and M.S. degrees from the University of
Michigan, and his M.D. from Harvard Medical School.
Representative terms from entire chapter:
advisory boards
